223 related articles for article (PubMed ID: 17655775)
1. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775
[TBL] [Abstract][Full Text] [Related]
2. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036
[TBL] [Abstract][Full Text] [Related]
3. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
[TBL] [Abstract][Full Text] [Related]
4. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
5. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
6. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
[TBL] [Abstract][Full Text] [Related]
7. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885
[TBL] [Abstract][Full Text] [Related]
8. Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells.
Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
Ann N Y Acad Sci; 2006 Nov; 1086():233-40. PubMed ID: 17185520
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma.
Kajiyama H; Kikkawa F; Suzuki T; Shibata K; Ino K; Mizutani S
Cancer Res; 2002 May; 62(10):2753-7. PubMed ID: 12019149
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of aminopeptidase N in non-small cell lung cancer.
Tokuhara T; Hattori N; Ishida H; Hirai T; Higashiyama M; Kodama K; Miyake M
Clin Cancer Res; 2006 Jul; 12(13):3971-8. PubMed ID: 16818694
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
[TBL] [Abstract][Full Text] [Related]
12. Expression, regulation and functional activities of aminopeptidase N (EC 3.4.11.2; APN; CD13) on murine macrophage J774 cell line.
Gabrilovac J; Cupić B; Zivković E; Horvat L; Majhen D
Immunobiology; 2011; 216(1-2):132-44. PubMed ID: 20638153
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Kawamura J; Shimada Y; Kitaichi H; Komoto I; Hashimoto Y; Kaganoi J; Miyake M; Yamasaki S; Kondo K; Imamura M
Hepatogastroenterology; 2007; 54(73):36-40. PubMed ID: 17419227
[TBL] [Abstract][Full Text] [Related]
14. Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis.
Fukasawa K; Fujii H; Saitoh Y; Koizumi K; Aozuka Y; Sekine K; Yamada M; Saiki I; Nishikawa K
Cancer Lett; 2006 Nov; 243(1):135-43. PubMed ID: 16466852
[TBL] [Abstract][Full Text] [Related]
15. Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells.
Mishima Y; Terui Y; Sugimura N; Matsumoto-Mishima Y; Rokudai A; Kuniyoshi R; Hatake K
Cancer Sci; 2007 Mar; 98(3):364-72. PubMed ID: 17270026
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma.
Ikeda N; Nakajima Y; Tokuhara T; Hattori N; Sho M; Kanehiro H; Miyake M
Clin Cancer Res; 2003 Apr; 9(4):1503-8. PubMed ID: 12684426
[TBL] [Abstract][Full Text] [Related]
17. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells.
Kajiyama H; Kikkawa F; Khin E; Shibata K; Ino K; Mizutani S
Cancer Res; 2003 May; 63(9):2278-83. PubMed ID: 12727850
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD13/aminopeptidase N on human gingival fibroblasts and up-regulation upon stimulation with interleukin-4 and interleukin-13.
Kunii R; Nemoto E; Kanaya S; Tsubahara T; Shimauchi H
J Periodontal Res; 2005 Apr; 40(2):138-46. PubMed ID: 15733148
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
Aozuka Y; Koizumi K; Saitoh Y; Ueda Y; Sakurai H; Saiki I
Cancer Lett; 2004 Dec; 216(1):35-42. PubMed ID: 15500947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
